PMC3530859_01
Hepatic volume since the initiation of mTOR inhibition therapy. Two-year followup by MRI. Month 0 = switch CsA to sirolimus. Month 24 = stop sirolimus because of absence of reduction growth of the hepatic volume and edema attributed to sirolimus.
CRIM.TRANSPLANTATION2012-513025.001.jpg
PMC3530859_01_CRIM.TRANSPLANTATION2012-513025.001.jpg
fig1
In November 2009, the liver volume was 4240 mL and in June 2010, 4400 mL (Figure 1). The liver volume was at 4700 mL (Figure 1).